Hosted on MSN

AtriCure’s Cryoanalgesia Study: A Potential Game-Changer in Post-Operative Pain Management

Atricure, Inc. ((ATRC)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights ...
Nasdaq

AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device

AtriCure, Inc. (ATRC) has launched the cryoSPHERE MAX cryoablation probe, which enhances Cryo Nerve Block (cryoNB) therapy by reducing freeze times by 50% compared to previous models and over 30% when ...
Hosted on MSN

AtriCure’s Cryoablation Study: A New Frontier in Pain Management

Atricure, Inc. ((ATRC)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights ...
Business Wire

AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
Nasdaq

AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...